Contact
searchSearch
HMP Global
Login

Suicide News

a man holds his head in his hands
News
Cohort Study Finds Increased Suicide Risk in Survivors of Traumatic Injury
01/21/2026
Maria Mantas
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after traumatic injury had a 9-fold higher risk of suicide than the general population 2 years after hospitalization, according to cohort study findings.
Patients discharged alive after...
01/21/2026
Psych Congress Network
US FDA building
News
FDA Requests Removal of Suicide Risk Warnings From GLP-1 RA Labels
01/14/2026
Maria Mantas
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug Administration (FDA) has requested the removal of information regarding the risk of suicidal ideation and behaviors (SI/B) from the labeling of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications.
The US Food and Drug...
01/14/2026
Psych Congress Network
A clinician and a patient
News
Cognitive Behavioral Therapy With Narrative Assessment Linked to Lower Suicide Attempt Risk
11/24/2025
Maria Mantas
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found that integrating a narrative component into cognitive behavioral therapy (CBT) substantially improved suicide prevention outcomes.
A recent meta-analysis found...
11/24/2025
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Evi Arthur
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
News
$52.5 Million Awarded in Federal Grants for Veteran Suicide Prevention
02/21/2024
Hannah Musick
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the US Department of Veterans Affairs announced it would award $52.5 million in grants to community-based organizations that provide or coordinate suicide prevention services for veterans and their families.
In a recent press release, the...
02/21/2024
Psych Congress Network
FDA
News
FDA Preliminary Evaluation Finds No Clear Link Between GLP-1 Drugs and Suicidal Thoughts, Cautions on Small Risk
01/26/2024
Meagan Thistle
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation...
01/26/2024
Psych Congress Network
Illustration two profiles with brains
News
Hospitalization Following Suicide Attempt May Benefit Some, but Individualized Approach Needed
10/25/2023
Brionna Mendoza
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may...
10/25/2023
Psych Congress Network
Teens with Headaches Report Increased Rates of Bullying, Suicidality
News
Teens With Headaches Report Increased Rates of Bullying, Suicidality
08/14/2023
Jolynn Tumolo
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been bullied or who have considered or attempted suicide may be more likely to experience headaches than their peers, according to study results published in Neurology.
Adolescents who have been...
08/14/2023
Neurology
News
Rumination Linked With Suicidal Thoughts in Teens With Major Depressive Disorder
04/17/2023
Jolynn Tumolo
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination was associated with suicidal ideation in adolescents with depression, according to findings published in the Journal of Affective Disorders
Elevated cognitive rumination...
04/17/2023
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use